Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
|
|
HOOKIPA Pharma Inc. (HOOK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/13/2023 |
8-K
| Appointed a new director|
Docs:
|
"HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors New York, US and Vienna, Austria, March 13, 2023 - HOOKIPA Pharma Inc. , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today that Terry Coelho will join its Board of Directors, Audit Committee and Compensation Committee, effective April 3, 2023. “Terry is an immensely valuable addition to our Board, given her experience in business strategy, broad financial transactions and business development, and we are thrilled to welcome her to the team,” said Joern Aldag, Chief Executive Officer at HOOKIPA. “Terry has worked with companies large and small and navigated fast-paced, complex business environments, including in the pharmaceutical sector. We will undoubtedly bene..." |
|
| 12/15/2022 |
8-K
| Quarterly results |
| 04/20/2022 |
8-K
| Appointed a new director|
Docs:
|
"HOOKIPA Pharma Appoints Tim Reilly, Ph.D. to its Board of Directors New York, US and Vienna, Austria, April 20, 2022 - HOOKIPA Pharma Inc. , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Tim Reilly, Ph.D. to its Board of Directors, effective immediately. “We’ re pleased to have Tim join our Board as we advance our oncology pipeline of novel arenaviral immunotherapeutics in and towards the clinic,” said Joern Aldag, Chief Executive Officer at HOOKIPA. “Tim’ s experience in product development, especially driving early clinical development that supports eventual marketed products, is enormously relevant to our current focus. We will benefit from his insights on our ongoing Phase 2 HB-200 program for hea..." |
|
|
|